Evidence map›Paper›PMID 27270539›Full record

ArticleChinese medical journal2016

Restoration of Brain Acid Soluble Protein 1 Inhibits Proliferation and Migration of Thyroid Cancer Cells.

Run-Sheng Guo, Yue Yu, Jun Chen, Yue-Yu Chen, Na Shen, Ming Qiu

Open access · goldAbstract read
In one paragraph

Article in Chinese medical journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Reactivation of the silencedProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. From inflammation to remodelling: A novel BASP1Journal of advanced research · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Run-Sheng GuoDepartment of General Surgery, Changzheng Hospital, Second Military Medical University, Shanghai 201705; Department of General Surgery, Jiading Central Hospital, Shanghai 201822, China.
Yue YuDepartment of General Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
Jun ChenDepartment of Pathology, Jiading Central Hospital, Shanghai 201822, China.
Yue-Yu ChenDepartment of General Surgery, Jiading Central Hospital, Shanghai 201822, China.
Na ShenDepartment of Otorhinolaryngology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Ming QiuDepartment of General Surgery, Changzheng Hospital, Second Military Medical University, Shanghai 201705, China.
Jiading District Central Hospital · CNSecond Military Medical University · CNThe First Affiliated Hospital, Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBrain acid soluble protein 1 (BASP1) is identified as a novel potential tumor suppressor in several cancers. However, its role in thyroid cancer has not been investigated yet. In the present study, the antitumor activities of BASP1 against the growth and migration of thyroid cancer cells were evaluated.

methodsBASP1 expression in thyroid cancer tissues and normal tissues were examined by immunohistochemical staining and the association between its expression and prognosis was analyzed. pcDNA-BASP1 carrying full length of BASP1 cDNA was constructed to restore the expression of BASP1 in thyroid cancer cell lines (BHT-101 and KMH-2). The cell proliferation in vitro and in vivo was evaluated by WST-1 assay and xenograft tumor models, respectively. Cell cycle distribution after transfection was analyzed using flow cytometry. Cell apoptosis after transfection was examined by annexin V/propidium iodide assay. The migration was examined using transwell assay.

resultsBASP1 expression was abundant in normal tissues while it is significantly decreased in cancer tissues (P = 0.000). pcDNA-BASP1 restored the expression of BASP1 and significantly inhibited the growth of BHT-101 and KMH-2 cells as well as xenograft tumors in nude mice (P = 0.000). pcDNA-BASP1 induced G1 arrest and apoptosis in BHT-101 and KMH-2 cells. In addition, pcDNA-BASP1 significantly inhibited the cell migration.

conclusionsDownregulation of BASP1 expression may play a role in the tumorigenesis of thyroid cancer. Restoration of BASP1 expression exerted extensive antitumor activities against growth and migration of thyroid cancer cells, which suggested that BASP1 gene might act as a potential therapeutic agent for the treatment of thyroid cancer.

Indexed as

AgedAnimalsApoptosisCalmodulin-Binding ProteinsCell CycleCell Line, TumorCell MovementCell ProliferationCytoskeletal ProteinsFemaleGene Expression Regulation, NeoplasticHumansMaleMembrane ProteinsMiceMice, NudeBASP1 protein, humanBasp1 protein, mouseCalmodulin-Binding ProteinsCytoskeletal ProteinsMembrane ProteinsNerve Tissue ProteinsRepressor Proteins

Identifiers

PMID27270539
PMCPMC4910367
OpenAlexW2410935167

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.